As reports appear about potential new Mesothelioma treatments, using genetically modified viruses, new tests for earlier diagnosis of the disease are also being trialled. As cases of the incurable lung cancer are increasing, and the current difficulties that oncologists have in making a correct diagnosis, finding a faster more accurate medical test to confirm the disease is vital in helping improve treatment options and survival rates. Although Mesothelioma is indeed a rare lung disease, the number of cases in the UK, and worldwide are increasing rapidly and expected to reach a peak in 2015. This is due to the long period of time it takes to develop any symptoms from the period of exposure to becoming ill.
The new test is reported to be based on measuring changes in the blood in order to detect cancer using a new instrument designed by Somalogic, Inc. This latest technology in detecting cancer is essential for earlier diagnosis of Mesothelioma so that current therapies and treatments have the best chance of improving the quality of life for the patients, if not facilitating a cure. It offers new hope for a fast, reliable and effective diagnosis and therefore access to earlier treatments to help patients live more comfortably with their illness.
As well as advances in early detection systems, scientists have reportedly made a major breakthrough for the treatment of asbestos related lung cancer too. The latest research to find a better treatment for Mesothelioma sufferers indicates that disrupting the function of cancer cells, using Oncolytic viral therapy can have a promising effect. Using genetically modified viruses to treat the disease, in this case, Newcastle Disease Virus (NDV), involved administering multiple doses of the virus to animals with Mesothelioma. Scientists observed that animals who received multiple doses responded better than those who just received a single dose. The report notes that although malignant Mesothelioma has no cure, by exploring all possible avenues of treatment an earlier, more effective treatment for the relief of the disease may be found. Currently, Mesothelioma is normally treated using chemotherapy, radiation therapy and surgery, and these are most effective during the early stages of the cancer. An early detection system can offer a better chance for asbestos related disease patients, in combination with new therapies, to treat it.
If you think you’ve been exposed to asbestos dust during the course of your former occupation and working conditions, contact Simpson Millar for a friendly chat about your legal position on 0808 129 3320.